Resultats de la cerca - Francis A. Farraye
- Mostrar 1 - 20 resultats de 43
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn’s Disease and Need for Parenteral Support Due to Short Bowel Syndrome–associated Intestinal Failure per Bharati Kochar, Millie D. Long, Edward Shelton, Lorraine S. Young, Francis A. Farraye, Vijay Yajnik, Hans Herfarth
Publicat 2016Artigo -
15
-
16
-
17
-
18
The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme per Francis A. Farraye, Taha Qazi, Paulo Gustavo Kotze, Gregory Moore, Rajiv Mundayat, Nervin Lawendy, Puza P. Sharma, Donna T. Judd
Publicat 2021Artigo -
19
Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy per Perry K. Pratt, Nunes David, H. Christian Weber, Frédéric F. Little, Themistoklis Kourkoumpetis, Gregory Patts, Janice Weinberg, Francis A. Farraye
Publicat 2018Artigo -
20
P388 Analysis of the impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis programme per Francis A. Farraye, Taha Qazi, Paulo Gustavo Kotze, Gregory Moore, C Kayhan, Rajiv Mundayat, Eric S. Maller, Chinyu Su, Arif Soonasra
Publicat 2019Artigo
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Disease
Inflammatory bowel disease
Gastroenterology
Ulcerative colitis
Immunology
Crohn's disease
Cancer
Colorectal cancer
Biology
Pathology
Coronavirus disease 2019 (COVID-19)
Dysplasia
Infectious disease (medical specialty)
Inflammatory Bowel Diseases
Intensive care medicine
Surgery
Adverse effect
Colonoscopy
Immune system
Virology
2019-20 coronavirus outbreak
Cohort
Family medicine
Inflammation
Outbreak
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Antibody
Biochemistry